PFSA
Profusa Inc (PFSA)
Healthcare • NASDAQ • $0.52+5.27%
- Symbol
- PFSA
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $0.52
- Daily Change
- +5.27%
- Market Cap
- $2.27M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $412.50
- 52W Low
- $0.41
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 0.45
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Company websiteResearch PFSA on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.